Interleukin-10 limits increased blood pressure and vascular RhoA/Rho-kinase signaling in angiotensin II-infused mice.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Life Science

• Publication date

  2016-01-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.lfs.2015.12.009PMID 26682936
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The immune system in hypertension.

  2014cited by this paper
• Interleukin-10 inhibits angiotensin II-induced decrease in neuronal potassium current.

  2013cited by this paper
• Interleukin-10 Released by CD4+CD25+ Natural Regulatory T Cells Improves Microvascular Endothelial Function Through Inhibition of NADPH Oxidase Activity in Hypertensive Mice

  2011cited by this paper
• Angiotensin II and the vascular phenotype in hypertension

  2011cited by this paper
• T lymphocytes: a role in hypertension?

  2010cited by this paper
• Biology of interleukin-10.

  2010cited by this paper
• Brain Microglial Cytokines in Neurogenic Hypertension

  2010cited by this paper
• IL-10 attenuates TNF-alpha-induced NF kappaB pathway activation and cardiomyocyte apoptosis.

  2009cited by this paper
• Endogenous Interleukin-10 Inhibits Angiotensin II–Induced Vascular Dysfunction

  2009cited by this paper
• The effects of 1 month antihypertensive treatment with perindopril, bisoprolol or both on the ex vivo ability of monocytes to secrete inflammatory cytokines.

  2009cited by this paper
• Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system.

  2007cited by this paper
• Role of the T cell in the genesis of angiotensin II–induced hypertension and vascular dysfunction

  2007cited by this paper
• Angiotensin II signal transduction through the AT1 receptor: novel insights into mechanisms and pathophysiology.

  2007cited by this paper
• Increased PDZ-RhoGEF/RhoA/Rho kinase signaling in small mesenteric arteries of angiotensin II-induced hypertensive rats

  2007cited by this paper
• Increased RhoA/Rho-Kinase Signaling Mediates Spontaneous Tone in Aorta from Angiotensin II-Induced Hypertensive Rats

  2006cited by this paper
• Molecular Aspects of Arterial Smooth Muscle Contraction: Focus on Rho

  2005cited by this paper
• Boosting interleukin-10 production: therapeutic effects and mechanisms.

  2005cited by this paper
• Antiinflammatory Effects of Angiotensin II Subtype 1 Receptor Blockade in Hypertensive Patients With Microinflammation

  2004cited by this paper
• Comparative effects of AT1-antagonism and angiotensin-converting enzyme inhibition on markers of inflammation and platelet aggregation in patients with coronary artery disease.

  2004cited by this paper
• Interleukins in Atherosclerosis: Molecular Pathways and Therapeutic Potential

  2003cited by this paper
• Recent advances in intracellular signalling in hypertension

  2003cited by this paper
• Enhanced Relaxation to the Rho-Kinase Inhibitor Y-27632 in Mesenteric Arteries from Mineralocorticoid Hypertensive Rats

  2001cited by this paper
• Possible Involvement of Rho-Kinase in the Pathogenesis of Hypertension in Humans

  2001cited by this paper
• Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension

  1997cited by this paper
• Regulation of human alveolar macrophage inflammatory cytokine production by interleukin-10.

  1996cited by this paper
• Vascular Changes in Hypertension

  1961cited by this paper

• The moderation effect of remnant cholesterol for linking cerebrospinal fluid interleukin 10 to blood pressure

  2026cites this paper
• Identifying pathways to cardiovascular mortality by causal graphical models and mediation analysis among hypertensive patients: insights from a prospective study

  2025cites this paper
• Immunomodulatory Activity of Cytokines in Hypertension: A Vascular Perspective

  2024cites this paper
• Elucidating the complex interplay between chronic kidney disease and hypertension

  2024cites this paper
• Resolution of inflammation, an active process to restore the immune microenvironment balance: A novel drug target for treating arterial hypertension.

  2024cites this paper
• Downregulation of inflammatory erectile dysfunction by Mantisa religiosa egg-cake through NO-cGMP-PKG dependent NF-kB signaling cascade activated by mixture of salt intake

  2023cites this paper
• Immune cells and hypertension

  2023cites this paper
• Insights into the roles of IL-10-producing regulatory B cells in cardiovascular disorders: Recent advances and future perspectives.

  2023cites this paper
• Exercise reduced the concentration of an inflammatory makers without modulating the levels of epigenetic marker potentially involved in hypertension: a preliminary study

  2023cites this paper
• A new immune disease: systemic hypertension

  2023cites this paper
• O-Linked β-N-Acetylglucosamine Modification: Linking Hypertension and the Immune System

  2022cites this paper
• Effects of Psidium guajava L. leaves extract on blood pressure control and IL-10 production in salt-dependent hypertensive rats.

  2022cites this paper
• Deeper insight into the role of IL-17 in the relationship beween hypertension and intestinal physiology

  2022cites this paper
• Inflammation and immunity connect hypertension with adverse COVID-19 outcomes

  2022cites this paper
• Pathophysiology of Cardiovascular Diseases: New Insights into Molecular Mechanisms of Atherosclerosis, Arterial Hypertension, and Coronary Artery Disease

  2022cites this paper
• Theories and Molecular Basis of Vascular Aging: A Review of the Literature from VascAgeNet Group on Pathophysiological Mechanisms of Vascular Aging

  2022cites this paper
• Sex Differences in the Immune System in Relation to Hypertension and Vascular Disease.

  2022cites this paper
• Epoxyeicosatrienoic Acid Analog and 20-HETE Antagonist Combination Prevent Hypertension Development in Spontaneously Hypertensive Rats

  2022cites this paper
• Deficiency of MicroRNA-181a Results in Transcriptome-Wide Cell-Specific Changes in the Kidney and Increases Blood Pressure

  2021cites this paper
• Ischemic Conditioning Ameliorated Hypertension and Vascular Remodeling of Spontaneously Hypertensive Rat via Inflammatory Regulation

  2021cites this paper
• Emerging roles of protein O-GlcNAcylation in cardiovascular diseases: Insights and novel therapeutic targets.

  2021cites this paper
• Interleukin-10 does not contribute to the anti-contractile nature of PVAT in health.

  2021cites this paper
• The role of interleukin-10 family members in cardiovascular diseases.

  2021cites this paper
• Deficiency of MicroRNA-181a Results in Transcriptome-Wide Cell Specific Changes in the Kidney that Lead to Elevated Blood Pressure and Salt Sensitivity

  2021cites this paper
• Inflammation: a mediator between hypertension and neurodegenerative diseases.

  2021cites this paper
• Resolvin-D1 attenuation of Angiotensin II-induced cardiac inflammation in mice is associated with prevention of cardiac remodeling and hypertension.

  2021cites this paper
• IL-1β and IL-10: diagnostic and prognostic potential of cytokines in the assessment of progression of non-alcoholic fatty liver disease in patients with hypertension

  2021cites this paper
• Diagnostic capabilities of kallistatin, IL-10 and IL-1? in patients with non-alcoholic fatty liver disease and hypertension

  2021cites this paper
• Decreased Absolute Number of Circulating Regulatory T Cells in Patients With Takayasu’s Arteritis

  2021cites this paper
• Interleukin-10 in the Vasculature: Pathophysiological Implications.

  2021cites this paper
• Immunity and Hypertension

  2020cites this paper
• Interleukin-9 Deletion Relieves Vascular Dysfunction and Decreases Blood Pressure via the STAT3 Pathway in Angiotensin II-Treated Mice

  2020cites this paper
• Mechanisms of vascular dysfunction in the interleukin-10-deficient murine model of preeclampsia indicate nitric oxide dysregulation.

  2020cites this paper
• Immune dyscrasia in adult growth hormone deficiency: Evaluation of hemolytic complement activity (CH50) and IgG subclasses.

  2020cites this paper
• Inhibition of sodium-proton-exchanger subtype 3-mediated sodium absorption in the gut: A new antihypertensive concept

  2020cites this paper
• IL-10 treatment decreases blood pressure in male, but not female, spontaneously hypertensive rats.

  2020cites this paper
• Overview of Hypertension Pathophysiology: New Insights into Oxidative Stress and Cytokines Roles

  2020cites this paper
• Antihypertensive effect of carvacrol is improved after incorporation in β‐cyclodextrin as a drug delivery system

  2020cites this paper
• Characterization and Significance of Monocytes in Acute Stanford Type B Aortic Dissection

  2020cites this paper
• Associations of Interleukin 10, Matrix Metallopeptidase 9, and Legumain with Blood Pressure Variability and Neurologic Outcomes in Patients with Ischemic Stroke

  2020cites this paper
• Catestatin (CST) is a key mediator of the immunoendocrine regulation of cardiovascular function

  2020cites this paper
• Renal Effects of Cytokines in Hypertension.

  2019cites this paper
• OP-CVRE180317 1102..1113

  2019cites this paper
• Hypertension in High School Students: Genetic and Environmental Factors: The HYGEF Study.

  2019cites this paper
• Crosstalk Between Vascular Redox and Calcium Signaling in Hypertension Involves TRPM2 (Transient Receptor Potential Melastatin 2) Cation Channel.

  2019cites this paper
• Endogenous Interleukin-10 Deficiency Exacerbates Vascular Pathology in Traumatic Cervical Spinal Cord Injury

  2019cites this paper
• Adaptive Immunity in Hypertension

  2019cites this paper
• Interleukin 10 And 18 levels in Essential Hypertensive

  2019cites this paper
• Arterial Hypertension and Interleukins: Potential Therapeutic Target or Future Diagnostic Marker?

  2019cites this paper
• Interleukin-12p35 knockout promotes macrophage differentiation, aggravates vascular dysfunction, and elevates blood pressure in angiotensin II-infused mice

  2018cites this paper
• Inflammation and oxidative stress markers in diabetes and hypertension

  2018influential citation
• Interleukin‐10 negatively modulates extracellular signal‐regulated kinases 1 and 2 in aorta from hypertensive mouse induced by angiotensin II infusion

  2018cites this paper
• The clinical potential of IL-12/IL-35 in treating chemotherapy drug-induced cardiac injury – Authors' reply

  2018cites this paper
• Plasmatic free light chains as inflammatory marker in insulin resistance: comparison of metabolic syndrome with adult growth hormone deficiency

  2018cites this paper
• Systemic Upregulation of IL-10 (Interleukin-10) Using a Nonimmunogenic Vector Reduces Growth and Rate of Dissecting Abdominal Aortic Aneurysm

  2018cites this paper
• Salt, Hypertension, and Immunity.

  2018cites this paper
• Inflammatory Signaling in Hypertension: Regulation of Adrenal Catecholamine Biosynthesis

  2018cites this paper
• O‐Glycosylation with O‐linked &bgr;‐N‐acetylglucosamine increases vascular contraction: Possible modulatory role on Interleukin‐10 signaling pathway

  2018cites this paper
• Renal effects of cytokines in hypertension

  2017cites this paper
• Investigating G protein-coupled receptor 35 signalling and its role in cardiovascular disease

  2017cites this paper
• OX40 regulates pressure overload-induced cardiac hypertrophy and remodelling via CD4+ T-cells.

  2016cites this paper